FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
Ignore the noise in GLP-1 stocks. Find the best value instead.
The deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its ...
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
Viking Therapeutics inks broad manufacturing pact with CordenPharma to support commercialization of VK2735: San Diego Wednesday, March 12, 2025, 17:00 Hrs [IST] Viking Therapeutic ...
Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...
NIH research in immunotherapy over decades literally has saved my life.